Limits of mendelian randomization analyses in selection of secretory phospholipase A2-IIA as a valid therapeutic target for prevention of cardiovascular disease

Robert S. Rosenson, Eva Hurt-Camejo

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageEnglish
Pages (from-to)942-943
Number of pages2
JournalJournal of the American College of Cardiology
Volume63
Issue number9
DOIs
StatePublished - 11 Mar 2014

Cite this